Decitabine and Cedazuridine in Combination With Venetoclax for the Treatment of Patients Who Have Relapsed Acute Myeloid Leukemia After Donor Stem Cell Transplant
PHASE2
This phase II trial tests how well decitabine and cedazuridine (DEC-C) work...
Clinical Trial to Assess the Safety and Tolerability of the Combination of Low-dose Cytarabine or Azacitidine Plus Venetoclax and Quizartinib in Newly Diagnosed AML Patients Aged Equal or More Than 60 Years Old
PHASE1
A phase I-II trial based on the combination of three drugs regimen LDAC or ...
Daratumumab, Azacitidine, and Dexamethasone for Treatment of Patients With Recurrent or Refractory Multiple Myeloma Previously Treated With Daratumumab
PHASE2
This phase II trial studies how well daratumumab, azacitidine, and dexameth...
A Study of Venetoclax in Combination With Azacitidine Versus Azacitidine in Treatment Naïve Participants With Acute Myeloid Leukemia Who Are Ineligible for Standard Induction Therapy
PHASE3
Acute Myeloid Leukaemia (AML) is an aggressive and rare cancer of myeloid c...